Free Trial

Russell Investments Group Ltd. Grows Position in Maximus, Inc. $MMS

Maximus logo with Business Services background

Key Points

  • Russell Investments Group Ltd. increased its holdings in Maximus, Inc. by 103.5% in Q1, now owning 79,593 shares valued at approximately $5.43 million.
  • Maximus has seen a consensus rating of "Buy" from analysts, despite a recent downgrade to a "hold" by Wall Street Zen.
  • The company declared a $0.30 quarterly dividend with a payout ratio of 22.10%, reflecting a yield of 1.4% for investors on the record by August 15th.
  • Need better tools to track Maximus? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Russell Investments Group Ltd. raised its position in Maximus, Inc. (NYSE:MMS - Free Report) by 103.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,593 shares of the health services provider's stock after purchasing an additional 40,487 shares during the quarter. Russell Investments Group Ltd. owned 0.14% of Maximus worth $5,427,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. LRI Investments LLC grew its stake in shares of Maximus by 11.9% in the first quarter. LRI Investments LLC now owns 1,833 shares of the health services provider's stock valued at $125,000 after buying an additional 195 shares in the last quarter. Vestcor Inc grew its stake in Maximus by 2.3% during the 1st quarter. Vestcor Inc now owns 9,877 shares of the health services provider's stock valued at $674,000 after purchasing an additional 223 shares in the last quarter. Cetera Investment Advisers grew its stake in Maximus by 5.8% during the 1st quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider's stock valued at $308,000 after purchasing an additional 247 shares in the last quarter. UMB Bank n.a. grew its stake in Maximus by 70.2% during the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after purchasing an additional 250 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its stake in Maximus by 0.7% during the 1st quarter. Nisa Investment Advisors LLC now owns 39,936 shares of the health services provider's stock valued at $2,723,000 after purchasing an additional 290 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, Maximus presently has a consensus rating of "Buy" and an average price target of $90.00.

Get Our Latest Analysis on Maximus

Insider Activity

In related news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the sale, the director owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.60% of the company's stock.

Maximus Trading Down 0.0%

NYSE:MMS opened at $85.2670 on Friday. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The business's 50 day moving average is $74.16 and its two-hundred day moving average is $70.99. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.94. The company has a market cap of $4.80 billion, a PE ratio of 15.70 and a beta of 0.60.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter last year, the business posted $1.74 EPS. Maximus's quarterly revenue was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus's dividend payout ratio (DPR) is 22.10%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines